Hyaluronic acid (oral + intra-articular)
Sleep & Recovery · Glycosaminoglycan
Tier B
Bottom line
Read Off Label grades Hyaluronic acid (oral + intra-articular) as B (6.8/10) based on moderate evidence, low-med benefit magnitude, and a low-risk safety profile.
AAOS 2021 guideline downgraded intra-articular HA to 'against' for knee OA citing inconsistent effects — decision remains debated.
Studied, labeled, or reported-use context: Oral: 80-200 mg/day; intra-articular: 20-40 mg series of 3-5 injections — OTC (oral); Rx; not individualized guidance.
What the evidence says
AAOS 2021 guideline downgraded intra-articular HA to 'against' for knee OA citing inconsistent effects — decision remains debated. Oral HA emerging: some evidence for skin and joints despite historical skepticism about absorption. Fasting administration appears in oral-use protocols.
Mechanism
Major glycosaminoglycan in synovial fluid; provides viscoelasticity and joint lubrication; binds water 1000x its weight; oral absorption modest but supports endogenous synthesis; intra-articular replaces synovial HA
Studied, labeled, or reported dose & route
Oral: 80-200 mg/day; intra-articular: 20-40 mg series of 3-5 injections
This records doses and routes described in studies, approved labeling, clinical practice, or documented use. It is not individualized guidance and does not establish safety; context changes with indication, formulation, health history, monitoring, and other medicines.
Citations
A link means the source informed this entry; it does not mean every claim on the page comes from that source. If a citation looks wrong or you want a claim re-checked, send a correction.
Common questions
- What does the evidence show about Hyaluronic acid (oral + intra-articular)'s effects?
- Read Off Label rates the evidence for Hyaluronic acid (oral + intra-articular) as Moderate and the benefit magnitude as low-med, producing an overall grade of B (6.8/10). AAOS 2021 guideline downgraded intra-articular HA to 'against' for knee OA citing inconsistent effects — decision remains debated.
- What safety findings are reported for Hyaluronic acid (oral + intra-articular)?
- Hyaluronic acid (oral + intra-articular) has a low risk profile in the database. Low (intra-articular: injection site pain, rare pseudosepsis; oral: essentially none) Legal status: OTC (oral); Rx (intra-articular — Synvisc, Euflexxa, etc.).
- What doses or routes are reported for Hyaluronic acid (oral + intra-articular)?
- Oral: 80-200 mg/day; intra-articular: 20-40 mg series of 3-5 injections This is context from studies, approved labeling, clinical practice, or documented use; it is not individualized guidance and does not establish safety.
- How does Hyaluronic acid (oral + intra-articular) work?
- Major glycosaminoglycan in synovial fluid; provides viscoelasticity and joint lubrication; binds water 1000x its weight; oral absorption modest but supports endogenous synthesis; intra-articular replaces synovial HA
This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.